Coronary disease & ACS

Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules

Circ Cardiovasc IntervPublished Retrospective cohort study

Main finding · Target-lesion failureResult — go to the resultAdjusted hazard ratio 1.10 95% CI 0.28–4.31

Authors' conclusion

In patients with OCT-defined CNs, OA- and IVL-assisted PCI resulted in comparable post-PCI minimal stent area and 2-year clinical outcomes.

Study context

Population
Patients with optical coherence tomography (OCT)-defined calcified nodules undergoing percutaneous coronary intervention (PCI) with pre- and post-PCI OCT, 2012–2022
Participants
167 patients
Exposure
Orbital atherectomy (OA) vs intravascular lithotripsy (IVL)-facilitated PCI
  • OAn = 83
  • IVLn = 84reference
Outcome
Imaging end point: minimal stent area on final post-PCI OCT; clinical end point: target-lesion failure:
  • Cardiac death
  • Target-vessel MI
  • Clinically driven target-lesion revascularization
Follow-up
2 years
Methodological detailspropensity score matching (sensitivity analysis)
  • Propensity score matching (sensitivity analysis)

Main finding

Target-lesion failure

Adjusted hazard ratio

1.10

95% CI 0.28–4.31

P = 0.89

By group

OA vs IVL
adjusted HR 1.10 (95% CI 0.28–4.31); P = 0.89

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeP value
Propensity score-matched population (n=68 per group)OA vs IVL · minimal stent area · matched cohortP = 0.73
Propensity score-matched population (n=68 per group)OA vs IVL · 2-year target-lesion failure · matched cohortlog-rank P=0.82

Original publication

Procedural and Clinical Outcomes After Orbital Atherectomy Versus Intravascular Lithotripsy in Patients With Calcified Nodules. Circ Cardiovasc Interv. Published 15 August 2025. doi:10.1161/circinterventions.125.015254

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.